SUMATRIPTAN HYDROXY OXINDOLE (25 mg) (1-[3-[2-(dimethylamino)ethyl]-3-hydroxy-2-oxo-1H-indol-5-yl]-N-methylmethanesulfonamide)

In Stock
Ready to ship

Catalogue No.

1A11880

CAS No.

2250254-19-2

Molecular Formula

C14H21N3O4S

Product Type

Pharmaceutical Analytical Impurities

$640.00

Quantity

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Current Lot Information

Current Lot:

F265E0

CAS RN®

2250254-19-2

Harmonized System (HS) Code *:

29359090

UN No:

N/A

NDC No:

N/A

Molecular Formula

C14H21N3O4S

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No

USP Certificates/Product Information Sheets and Valid Use Dates

Valid Use Date

Country of Origin*

Material Origin*

F265E0

1A11880-F265E0

See Product Information Sheet

India

Chemical Synthesis

Lot No

F265E0

USP Certificates/Product Information Sheets and Valid Use Dates

Chemical Synthesis

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

No data available

Frequently bought together

Catalogue No.

1A11880

CAS No.

2250254-19-2

Molecular Formula

C14H21N3O4S

Product Type

Pharmaceutical Analytical Impurities

Catalogue No.

1A10040

CAS No.

260435-42-5

Molecular Formula

C15H19N5O

Product Type

Pharmaceutical Analytical Impurities

Catalogue No.

1A10220

CAS No.

86-48-6

Molecular Formula

C11H8O3

Product Type

Pharmaceutical Analytical Impurities